Hermes Medical Solutions introduces HERMIA at BNMS
Hermes Medical Solutions is introducing HERMIA, a new version of its all-in-one molecular imaging software, with exciting new functionality, at the spring BNMS meeting.
HERMIA’s powerful and vendor-neutral software enables clinicians and technologists to simplify their workflow, increase consistency and quality and keep pace with the fast development of scanners, tracers and procedures in molecular imaging.
HERMIA’s state-of-the-art software suite provides fast and accurate reporting for all clinical scenarios in PET/SPECT/CT/MR, remote reporting, and dosimetry – irrespective of camera manufacturer.
With its powerful and robust data management, HERMIA simplifies a department’s workflow, improving efficiency and accuracy at every step. HERMIA can even be launched directly from PACS.
HERMIA exploits AI and the latest computing technology to accelerate reporting with a fast and intuitive user interface. HERMIA’s intelligent data loading, sub-second automatic registration, real-time registration refinement, automatic segmentation and longitudinal lesion tracking shortens reporting times.
Adding to its trusted and comprehensive toolbox for NM processing, HERMIA now includes increased automation and SeHCAT analysis.
HERMIA’s SPECT reconstruction uses AI-driven automatic motion correction and advanced PET reconstruction techniques to improve image quality, helping to make faster and more accurate diagnoses. HERMIA provides quantitatively accurate SPECT reconstruction for therapeutic radiopharmaceuticals, notably for Y-90 SPECT for SIRT.
With its fast Monte-Carlo-based calculations, HERMIA features the only CE-marked dosimetry solution that is truly personalized to the patient’s anatomy and that supports single time point imaging for all therapeutic radiopharmaceuticals. HERMIA drastically reduces the required camera time and improves the patient experience, making dosimetry a practical, everyday reality.
This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine. Visit our dedicated BNMS conference page to find out more.
